EcoDrugPlus

Trace Amine Associated Receptor 1

Ensembl ID : ENSAPEG00000013623
Gene Symbol: TAAR1
2 Cross references
432 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSAPEG00000013590
Gene Symbol: TAAR1
2 Cross references
384 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSAPEG00000013609
Gene Symbol: TAAR1
2 Cross references
384 Possible Orthologues:

Transforming Growth Factor, Beta Receptor 1 B

Ensembl ID : ENSAPEG00000010010
Gene Symbol: TGFBR1B
1 Cross references
205 Possible Orthologues:

Transient Receptor Potential Cation Channel, Subfamily A, Member 1b

Ensembl ID : ENSAPEG00000021903
Gene Symbol: TRPA1B
1 Cross references
201 Possible Orthologues:

Tryptophan Hydroxylase 1 (Tryptophan 5-Monooxygenase) A

Ensembl ID : ENSAPEG00000023092
Gene Symbol: TPH1A
1 Cross references
202 Possible Orthologues:

Tubulin, Alpha 8 Like 2

Ensembl ID : ENSAPEG00000014468
Gene Symbol: TUBA8L2
2 Cross references
158 Possible Orthologues:

Tubulin, Beta 2a Class Iia

Ensembl ID : ENSAPEG00000005474
Gene Symbol: TUBB2
1 Cross references
223 Possible Orthologues:

Tubulin, Beta 5

Ensembl ID : ENSAPEG00000010955
Gene Symbol: TUBB5
1 Cross references
253 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSAPEG00000017027
Gene Symbol: TYR
1 Cross references
203 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSAPEG00000021548
Gene Symbol: TYR
2 Cross references
196 Possible Orthologues:

Tyrosine Hydroxylase

Ensembl ID : ENSAPEG00000010338
Gene Symbol: TH
1 Cross references
188 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).